DeNovo NT Ankle LDC Study

Status unconfirmed

Conditions studied: Defect of Articular Cartilage, Osteochondral Lesion of Talus, Osteochondritis Dissecans

In brief

The purpose of this post-market clinical study is to collect long-term outcomes for DeNovo NT Graft treatment of articular cartilage lesions in the ankle in a standard clinical setting. Outcomes to be assessed include pain, function, activity levels and healthcare resource use.

Key facts

Study ID
NCT01347892
Run by
Zimmer Orthobiologics, Inc.
People needed
205
Starts
2011-03-01
Expected to finish
2019-09-01
Last updated by the study team
2017-01-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.